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Abstract 26 
Campylobacter jejuni is recognized as an important causative agent of bacterial 27 
gastroenteritis in the developed world. Despite the identification of several factors 28 
contributing to infection, characterization of the virulence strategies employed by C. 29 
jejuni remains a significant challenge. Bacterial autotransporter proteins are a major 30 
class of secretory proteins in Gram-negative bacteria and notably many 31 
autotransporter proteins contribute to bacterial virulence. The aim of this study was to 32 
characterise the C. jejuni 81116 C8J_1278 gene (capC), predicted to encode an 33 
autotransporter protein, and examine the contribution of this factor to virulence of 34 
Campylobacter jejuni.  The predicted CapC protein has a number of features that are 35 
consistent with autotransporters including the N-terminal signal sequence and the C-36 
terminal β-barrel domain and was determined to localise to the outer membrane.  37 
Inactivation of the capC gene in C. jejuni 81116 and C. jejuni M1 resulted in reduced 38 
insecticidal activity in Galleria mellonella larvae.  Furthermore, C. jejuni capC mutants 39 
displayed significantly reduced adherence to and invasion of non-polarized, partially 40 
differentiated Caco-2 and T84 intestinal epithelial cells. Gentamicin treatment showed 41 
that the reduced invasion of the capC mutant is primarily caused by reduced 42 
adherence to intestinal epithelial cells, not by reduced invasion capability. C. jejuni 43 
capC mutants caused reduced IL-8 secretion from intestinal epithelial cells and elicited 44 
a significantly diminished immune reaction in Galleria larvae indicating that CapC 45 
functions as an immunogen. In conclusion, CapC is a new virulence determinant of C. 46 
jejuni that contributes to the integral infection process of adhesion to human intestinal 47 
epithelial cells.  48 
 49 
 50 
3 
 
Importance 51 
Campylobacter jejuni is a major causative agent of human gastroenteritis, making this 52 
zoonotic pathogen of significant importance to human and veterinary public health 53 
worldwide. The mechanisms by which C. jejuni interacts with intestinal epithelial cells 54 
and cause disease are still poorly understood due, in part, to the heterogeneity of C. 55 
jejuni infection biology.  Given the importance of C. jejuni to public health, the need to 56 
characterize novel and existing virulence mechanisms is apparent.  The significance 57 
of our research is in demonstrating the role of CapC a novel virulence factor in C. jejuni 58 
that contributes to adhesion and invasion of the intestinal epithelium, thereby in part, 59 
addressing the dearth of knowledge concerning the factors involved in Campylobacter 60 
pathogenesis and the variation observed in severity of human infection.   61 
 62 
INTRODUCTION 63 
Campylobacter jejuni is a Gram-negative, microaerophilic bacterium which is 64 
recognized as the foremost cause of bacterial foodborne gastroenteritis worldwide [1]. 65 
Infection is often self-limiting and is frequently acquired through the consumption of 66 
contaminated poultry and poultry products. It is estimated that Campylobacter causes 67 
1.3 million cases of food poisoning in the US and 280 000 cases in the UK each year 68 
[2].  Moreover, campylobacteriosis poses a heavy economic burden, costing the US 69 
economy and estimated $1.7 billion p/a and the UK economy an estimated £900 70 
million p/a [3, 4]. 71 
The availability of a wealth of genomic information and the development of molecular 72 
tools for the study of Campylobacter has led to the identification of several factors 73 
integral to human infection and chicken colonization [5–7].  74 
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C. jejuni transiently colonizes the human intestinal tract, causing a mild watery 75 
diarrhoea but can also cause a more severe inflammatory and bloody diarrhoea [7–76 
10]. These diverse clinical manifestation may reflect differences in virulence potential 77 
of C. jejuni isolates. The processes of adhesion to, invasion of and translocation 78 
across the intestinal epithelium have been shown to be essential requirements to 79 
determine pathogenicity of C. jejuni, yet the mechanisms C. jejuni uses for adhesion 80 
and invasion and whether these processes are intrinsically related is not entirely 81 
understood [11, 12].  C. jejuni isolates have been shown to vary considerably in their 82 
ability to both adhere and invade intestinal epithelial cells [13, 14]. There is also a 83 
degree of variation reported in the translocation potential of C. jejuni, and 84 
inconsistencies as to the route by which C. jejuni crosses the epithelium [15]. 85 
Furthermore, different C. jejuni genotypes vary in their infection biology of the chicken 86 
host [13, 16]; these inconsistencies may reflect varying infection capability between 87 
different genotypes.  88 
In excess of 40 genetic factors have been reported to contribute to C. jejuni adhesion 89 
and invasion [17]. The precise influence and relative importance of each of these 90 
pathogenicity-associated factors to adhesion, invasion and translocation of C. jejuni at 91 
the epithelial interface is unknown however.  A clearer understanding of all of the 92 
factors contributing to this interaction is required to clarify the events during C. jejuni 93 
adhesion to and invasion of enterocytes in order to understand variation in virulence 94 
and clinical manifestation. 95 
Bacterial autotransporters are the largest and most diverse class of surface exposed 96 
or secreted proteins in Gram negative bacteria [18, 19]. These proteins share a 97 
common mechanism of export, conferred by their C-terminal β-barrel structure, and 98 
play a wide variety of roles in pathogenesis and virulence conferred by their N-terminal 99 
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functional or “passenger” domain [20]. Significantly, all characterised autotransporter 100 
proteins are implicated in virulence to some extent [18].  Notable autotransporters 101 
include the Bordetella pertussis protein Pertactin; a key component of epitopes 102 
included in the whooping cough vaccine [21], Yap proteins in Yersinia pestis and 103 
VacA; the pore-forming, vacuolating cytotoxin in Helicobacter pylori [18].   104 
The capA (cj0628/9) and capB (cj1677/8) genes of C. jejuni NCTC 11168 were the 105 
first two autotransporters identified in C. jejuni [22]. CapA has been shown to 106 
contribute to adherence to Caco-2 cells and chicken LHM cells, and absence CapA 107 
impaired colonisation of chickens [22].  However, a separate study concluded that 108 
CapA had no effect on broiler colonisation [5]. Furthermore, the capA gene is not 109 
present in all C. jejuni isolates so is likely dispensable [5], and no discernible role has 110 
been ascribed to CapB [5]. These autotransporters are absent in C. jejuni M1 and C. 111 
jejuni 81116 (NCTC 11828), two other reference strains that were isolated from 112 
chickens and humans, respectively [23–25]. In the absence of capA and capB, these 113 
strains can be expected to encode other genetic factors to compensate. 114 
Here, we characterised another putative autotransporter encoding gene is the C. jejuni 115 
81116 C8J_1278 locus [26], which bears no sequence identity with other 116 
autotransporters identified in C. jejuni and has been tentatively named CapC. Given 117 
the plethora of literature citing the involvement of autotransporters in virulence [18, 22, 118 
27–30], we hypothesised that CapC serves as a virulence determinant in C. jejuni, and 119 
show here data supporting this hypothesis. 120 
 121 
 122 
 123 
 124 
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 125 
RESULTS 126 
Characterisation of a novel Campylobacter autotransporter protein 127 
The predicted protein sequence encoded by capC (Genbank: ABV52877.1) was used 128 
to identify potential conserved domains using the NCBI Conserved Domain Database. 129 
The CDD query tool allowed the identification of structural motifs in the C-terminal 130 
thirds of the CapC sequence (residues 490-750). The CDD search successfully 131 
identified an autotransporter beta-domain in this region; found in all autotransporter 132 
proteins, thus denoting CapC as a member of this family (Figure 1).  The SignalP 4.1 133 
server was successfully utilized to predict the presence and location of a signal peptide 134 
sequence motif in the CapC amino acid sequence.  The first 25 amino acids in the 135 
CapC sequence represent the N-terminal signal sequence of this autotransporter and 136 
this sequence is cleaved after this residue.  The subcellular localisation prediction tool 137 
Cello V2.5 is commonly used to predict the localisation of prokaryotic and eukaryotic 138 
proteins. Use of the Cello localisation tool suggests that CapC is ultimately an 139 
extracellular, secreted protein. An alternative localization prediction tool is PSORTb. 140 
CapC is predicted by PSORTb to be primarily an outer membrane protein as one might 141 
expect from an autotransporter, however there was a lower prediction score for the 142 
likelihood of CapC being an extracellular protein. Phyre2 was successfully used in this 143 
study to build a partial 3D model of the CapC protein based on remote homology 144 
detection methods.  The model of the CapC protein structure shows the clearly defined 145 
14 amphipathic strands comprising the beta-barrel that is characteristic of all 146 
autotransporters, further confirming CapC as a member of this family. Outputs from 147 
these analyses are shown in Figure S1A-C and Table S1 [31–34]. 148 
 149 
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capC encodes an outer membrane protein which does not affect C. jejuni growth 150 
Antibodies against a CapC-specific peptide were raised in rabbits. Crude rabbit sera 151 
recognised a ~43kDa protein in whole cell preparations (Figure 2A).  Interestingly, an 152 
additional protein band was detected at ~25Kda which may represent a folded form of 153 
CapC. Only the ~43KDa CapC protein was detected in the outer membrane fractions 154 
of wildtype C. jejuni 81116 and C. jejuni M1 (Figure 2B and 2C), indicating that CapC 155 
is an outer-membrane anchored protein and does not appear to be secreted 156 
extracellularly in its native form.  Anti-MOMP antibodies were used as positive controls 157 
and to ensure purity of outer membrane fractions (Figure S2) [35]. 158 
To assess the role of CapC in C. jejuni, isogenic mutants of capC were constructed in 159 
C. jejuni 81116 and C. jejuni M1 by insertion of a chloramphenicol resistance cassette.  160 
We were unable to complement the capC mutants as we were unable to clone the 161 
capC coding sequence into the pC46 or pSV009 complementation vectors in the 162 
correct orientation, despite repeated attempts [36–38]. 163 
The capC mutants lacked expression of CapC as determined by immunoblotting 164 
(Figure 1A) and inactivation of capC did not affect growth of C. jejuni or reduce 165 
capability to survive exposure to aerobic conditions (Figure S3,S4).  166 
 167 
Inactivation of capC causes decreased virulence in the Galleria mellonella insect 168 
model 169 
A larval survival assay and a morbidity and mortality screen were employed to assess 170 
the contribution of CapC to virulence. Larvae survival levels were used as an indicator 171 
of virulence. The proportion of surviving larvae infected with mutant strains was 172 
significantly (p<0.05) increased as compared to wildtype strains from 6-48 hours post 173 
infection (Figure 3). Mock infected larvae showed 100% survival rates over 48 hours. 174 
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These results suggest that inactivation of capC causes decreased C. jejuni virulence 175 
in the Galleria model. 176 
The contribution of capC to morbidity and mortality in the Galleria model was also 177 
assessed over a period of 24 hours post-challenge on the basis of their ability to move, 178 
melanisation and death using the scoring system outlined in Table S3.  C. jejuni 81116 179 
and C. jejuni M1 capC mutant strains exhibited significantly decreased morbidity and 180 
mortality in the Galleria model compared to parental strains based on all criteria 181 
(Figure 4A+ 4B). Wildtype strains consistently elicited mortality rates of 90-100% 182 
whereas C. jejuni 81116 capC caused 10-33% mortality (q<0.001) and C. jejuni M1 183 
capC mutant caused 0-57% mortality (q<0.001).  Notably, deletion of capC did not 184 
result in a complete cessation in virulence. Galleria mellonella larvae exhibit 185 
discolouration upon infection which is an immune response that results in the 186 
deposition of melanin to encapsulate pathogens.  capC mutants caused significantly 187 
decreased melanisation (q<0.001) suggesting CapC is an immunogenic factor that 188 
contributes to the inflammatory response in vivo. 189 
 190 
CapC is required for maximal adhesion to Caco-2 and T84 intestinal epithelial 191 
cells 192 
In order to further investigate the virulence phenotype with which CapC has been 193 
correlated, a combination of Caco-2 colorectal epithelial cells and T84 colonic 194 
epithelial cell culture models were used. Figure 5A shows adhesion and invasion 195 
efficiencies of C. jejuni 81116 and C. jejuni M1 and their respective capC mutants in a 196 
partially differentiated Caco-2 cell model while Figure 5B shows adhesion and invasion 197 
efficiencies of C. jejuni 81116 and C. jejuni M1 and their respective capC mutants in a 198 
T-84 cell model. Inactivation of capC resulted in significantly reduced adherence and 199 
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invasion of non-polarized partially differentiated Caco-2 cells relative to wildtype 200 
strains (p=0.006).   201 
The capC mutants also show reduced adhesion and invasion efficiency in a T84 non-202 
polarized adhesion and invasion model; although this reduction was not statistically 203 
significant in the T84 cell culture model (p=0.06), it was a consistent phenotype 204 
observed for both C. jejuni 81116 and C. jejuni M1.  205 
In order to assess whether inactivation of capC affected invasion or indirectly via 206 
reduced adherence, the number of C. jejuni surviving gentamicin treatment was 207 
represented as a proportion of the number of total associated bacteria (from which the 208 
number of adherent bacteria are calculated), and compared (Figure 5C).  The capC 209 
mutant strains show a slight increase in the proportion of invaded bacteria as 210 
compared to their coupled wildtype strains demonstrating that CapC does not cause 211 
a proportional decrease in invasion capacity. Therefore, results from adhesion and 212 
invasion assays using Caco-2 and T84 cell lines indicate that CapC directly impacts 213 
upon adhesion of C. jejuni 81116 and C. jejuni M1 in vitro, thereby subsequently 214 
reducing invasion efficiency. 215 
 216 
CapC contributes to IL-8 secretion but does not impact on cytotoxicity 217 
Wildtype C. jejuni and capC mutant strains were compared for cytotoxic activity 218 
against Caco-2 cells (Figure S5). C. jejuni 81116 elicited marginally greater cytotoxicity 219 
than its capC mutant counterpart, though this difference was found not to be 220 
statistically significant (p=0.09). The difference in cytotoxicity elicited between C. jejuni 221 
M1 and C. jejuni M1 capC was minimal (p=0.389,). These data suggest that CapC 222 
does not mediate cytotoxicity and that levels of cytotoxicity differ markedly between C. 223 
jejuni strains. 224 
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IL-8 is functionally analogous to insect chemoattractants, such as plasmatocyte 225 
spreading peptide (PSP), that promote haemocyte migration and melanin deposition 226 
in Galleria larvae and other insects [39]. Given that capC gene deficiency caused 227 
decreased melanisation, presumably through a lack of stimulation of the immune 228 
system of Galleria, we aimed to investigate whether capC gene deficiency also caused 229 
decreased activation of IL-8.  The capC mutants of C. jejuni 81116 and C. jejuni M1 230 
induced a decreased IL-8 response from T84 intestinal epithelial cells compared to 231 
respective wildtype strains (Figure 6). This was more pronounced with C. jejuni M1 232 
compared to C. jejuni 81116.  capC mutant show a greater reduction in IL-8 secretion 233 
(p<0.05) than the wildtype C. jejuni.  These phenotypes are reflective of adhesion and 234 
invasion phenotypes observed in the T84 cell model. Whist the magnitude of the 235 
decrease in IL-8 secretion from T84 cells is not consistent between the two capC 236 
mutant strains, the observed decrease indicates that CapC may play a role in 237 
elicitation of immune responses from human intestinal epithelial cells.   238 
 239 
DISCUSSION 240 
During infection, damage to the human gut is mediated by C. jejuni adhesion to, 241 
invasion and translocation across the epithelium [8, 14, 40]. Many Campylobacter 242 
genes have been proposed to be involved in this interaction and variety of 243 
mechanisms by which these events occur have been reported [8, 14, 40–42]. These 244 
include the fibronectin binding proteins CadF and FlpA [5, 43], the flagellar [44] and 245 
genes encoding surface structures such capsule biosynthesis genes, LOS and CPS 246 
[15, 45]. A number of metabolism-related genes have also been reported to be 247 
involved in adhesion and invasion, though these may merely be required for survival 248 
of C. jejuni during infection [46, 47]. Furthermore, the host receptors, kinases and 249 
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pathways involved in C. jejuni binding and cell entry are not very well characterized 250 
[14].   Autotransporters are a class of secretory proteins in Gram-negative bacteria, all 251 
of which possess a unifying structure; a single polypeptide composed of an N-terminal 252 
signal peptide and passenger domain, which confer targeting to the inner membrane 253 
and a virulence function respectively [18–20, 29].  The C-terminal β-barrel domain, or 254 
autotransporter domain, is thought to form a pore in the outer membrane through 255 
which the passenger domain is secreted [20].  The only autotransporters identified in 256 
C. jejuni to date are CapA, CapB and an additional autotransporter encoded by the 257 
CJ81176_1367 locus in C. jejuni 81-176 [22, 48]. CapA is an autotransporter that was 258 
previously shown to function as an auxiliary adhesin and may contribute to chicken 259 
colonisation [22]. The role of autotransporters in Gram negative pathogens is diverse 260 
and not limited to adhesion to host cells; these proteins commonly function as serine 261 
proteases, esterases, mucinases, toxins and haemagglutinins [18]. In this study we 262 
have characterised a novel autotransporter in C. jejuni, which we have termed CapC.  263 
Bioinformatic analysis has revealed that CapC possesses a number of molecular 264 
features consistent with previously characterized autotransporter proteins including 265 
the N-terminal signal sequence and the C-terminal barrel domain [30]. We have shown 266 
that CapC is an outer membrane protein as predicted using bioinformatics tools; this 267 
is another feature that is consistent with CapC belonging to the autotransporter family. 268 
Given the functions of autotransporters, CapC is a putative virulence determinant in 269 
C. jejuni which may contribute to infection processes.  270 
The larvae of the Greater Wax Moth (Galleria mellonella) have been used previously 271 
as an effective and powerful model to identify putative virulence determinants in a 272 
range of pathogens including C. jejuni [49–52]. This model has been used to 273 
demonstrate that mutants with deletions in factors that have previously been 274 
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implicated as virulence determinants elicit decreased mortality in the Galleria model, 275 
relative to wildtype strains [45, 53].  In addition to being an effective and ethical 276 
alternative to animal models, the Galleria mellonella virulence model provides a 277 
quantifiable measure of virulence within the context of a functional immune system 278 
[52, 54, 55].  279 
We have demonstrated that inactivation capC impairs virulence of C. jejuni in Galleria 280 
larvae as determined by mortality/survival rates and severity of disease (morbidity).. 281 
However, the mechanism by which CapC contributes to insecticidal activity and 282 
therefore virulence in this model is unclear. For example, loss of capsule modification 283 
capability conferred by MeOPN of Campylobacter has been shown to cause reduced 284 
virulence in the Galleria model [45, 56]. MeOPN has been shown not to have inherent 285 
insecticidal activity however [45], suggesting that reduced virulence is a result of 286 
impaired bacterial fitness.  Conversely, inactivation of the Dot/Icm type IV secretion 287 
system in Legionella pneumophila abolished virulence in Galleria suggesting that 288 
intracellular survival and bacterial proliferation are key to virulence [57]. Given that 289 
absence of CapC results in decreased adhesion to human intestinal epithelial cells, it 290 
is likely that reduced virulence associated with capC mutants is due to reduced 291 
interaction with epithelial cells. Galleria mellonella and other insects such as 292 
Drosophila, exhibit a melanization response upon infection [49]. The melanisation 293 
process is an innate immune response mediated by phenoloxidase (PO) [49, 52, 58]. 294 
Melanization is triggered by recognition of microbial products, which are often surface 295 
exposed, by soluble pattern recognition receptors. This causes a serine protease 296 
cascade resulting in cleavage of ProPO to PO, which in turn, converts phenols to 297 
quinines which polymerase to form melanin [48, 50].  Melanin is deposited to 298 
encapsulate pathogens, resulting in pigmentation of the larvae [49, 58].  This process 299 
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is analogous to abscess formation induced  bymammalian infections [49], and can be 300 
considered to be part of the inflammatory immune response of these insects . 301 
In this study we have demonstrated that absence of CapC results in a reduced immune 302 
response from Galleria, as wildtype strains consistently caused a significantly greater 303 
degree of colour change in Galleria, indicative of a greater degree of melanization.  304 
Absence of CapC also resulted in a reduced inflammatory response from human 305 
intestinal cells as wildtype strains elicited higher IL-8 secretion levels than capC 306 
mutants.  IL-8 is a pro-inflammatory cytokine that plays a key role in mobilising cellular 307 
defence mechanisms. C. jejuni has been demonstrated to stimulate IL-8 secretion 308 
from human intestinal cells in vitro via the NF-kB pathway which is a major downstream 309 
target of TLR signalling pathways [59]. Therefore any change in IL-8 secretion 310 
associated with inactivation of capC may be indicative of a change in interaction of C. 311 
jejuni with the epithelial cell surface. Furthermore, it has been shown that C. jejuni-312 
induced IL-8 secretion via MAP kinase stimulation is dependent upon gene products 313 
that are expressed upon contact with epithelial cells [59, 60]. The degree of IL-8 314 
secretion in C. jejuni M1 was considerably greater than that elicited by C. jejuni 81116 315 
which correlates with the virulence profiles of these strains in the Galleria model 316 
(Figure 6).  Despite causing high levels of morbidity and mortality at 24 hours post 317 
infection, the comparatively low IL-8 secretion elicited by C. jejuni 81116 wildtype at 4 318 
hours post infection is likely due to the slower growth rate of this strain (Figure S4).  319 
Previous studies have shown that the flagella, CDT and OMVs of Campylobacter have 320 
been shown to elicit secretion of IL-8 via activation of TLRs [59]. Whether CapC elicits 321 
secretion of IL-8 directly or merely inhibits the capacity of other factors to do so is 322 
unclear, however, the observed decrease in IL8 secretion suggests that absence of 323 
CapC affects interactions with epithelial cells.   324 
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In addition to fibronectin binding proteins such as CadF and FlpA, factors such as JlpA 325 
[61], Peb1a [62], and CapA [22] are reported to influence adhesion to varying extents. 326 
This multitude of reported adhesins has complicated understanding of the adhesion 327 
process, and is further complicated by the failure to distinguish between factors 328 
contributing to bacterial fitness and “true” adhesins involved in direct interaction with 329 
the host [62]. Furthermore, most of the reported adherence-impaired single gene 330 
mutants in genes encoding the aforementioned factors, exhibit only reduced rather 331 
than abolished interactions with eukaryotic cells [63]. This observation suggests that 332 
redundancy of factors may exist in the adhesion process, a compelling notion 333 
considering the number of reported factors and that certain adhesins are not 334 
conserved amongst C. jejuni lineages [22].  A combination of non-polarised, partially 335 
differentiated Caco-2 cells and non-polarised T84 cells were used to demonstrate that 336 
CapC contributes to adhesion in these models. Adhesion and invasion efficiencies of 337 
capC mutants were decreased in the T84 cells model and significantly decreased in 338 
the Caco-2 cell model. Subsequent comparison of the levels of invaded C. jejuni as a 339 
proportion of associated bacteria revealed that mutant strains showed marginally 340 
increased proportional invasion. Therefore, the observed phenotypes indicate that 341 
CapC is required for maximal adhesion to human intestinal cells. Identification of CapC 342 
as an additional autotransporter contributing to adhesion suggests that C. jejuni does 343 
not have a defined, uniform method of adhesion and invasion of intestinal cells.  The 344 
results presented here support a case that adhesion, and consequently invasion, are 345 
dependent on the cooperative action of several different factors. Moreover, certain 346 
adhesins are not conserved between different C. jejuni strains which indicates that 347 
different Campylobacter lineages have different mechanisms of interaction with the 348 
host and different strategies of colonisation.  349 
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Identification of a specific role for CapC in the human niche raises the question as to 350 
whether CapC plays a role in the interaction with the chicken host. The outer 351 
membrane is the interface for interaction with the host and environment and many 352 
genes involved in interaction with the human host are also implicated in colonisation 353 
of the chicken [6, 42, 64, 65]. For example, CadF and FlpA bind fibronectin in both 354 
chickens and human cell models though do differ in their expression in each host [5, 355 
14]. The CapA autotransporter is involved in adherence to both human intestinal 356 
epithelial cells and chicken liver epithelial cells and has been linked to chicken 357 
colonisation, although it has also shown to be dispensable in certain strains [5, 22].  358 
Additionally, a cj0511 serine pepidase mutant that was attenuated in G. mellonella, 359 
was shown to have severely reduced capacity for chicken colonisation [66].  360 
In this study, we have investigated the contribution of CapC to the virulence of 361 
Campylobacter. We have shown that CapC is possesses a number of features 362 
consistent with autotransporters including the autotransporter domain which is unique 363 
to members of this protein class. Using the Galleria mellonella model, we have shown 364 
that capC significantly contributes to virulence in vivo, and likely functions as an 365 
adhesin and immunogenic factor. Furthermore, our findings highlight that 366 
Campylobacter uses a variety of mechanisms involved in virulence, with many of these 367 
being multifactorial and variable between isolates and genetic backgrounds.  368 
 369 
 370 
MATERIALS AND METHODS 371 
Bacterial strains and culture conditions 372 
C. jejuni 81116 (NCTC 11828) and C. jejuni M1 and their respective capC mutant 373 
derivatives were routinely cultured on Mueller-Hinton agar (MHA) supplemented with 374 
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5% sheep blood or in Mueller-Hinton broth (MHB) and incubated at 42oC in a 375 
microaerobic atmosphere generated utilising Campygen gas packs (Oxoid, UK) (5% 376 
O2, 10% CO2 and 85% N2).  Cultures were supplemented with trimethoprim (100 μg 377 
ml-1), chloramphenicol (10 μg ml-1) and/or kanamycin (50 μg ml-1) where appropriate. 378 
Escherichia coli DH5 alpha and Escherichia coli JM109 were used for propagation of 379 
plasmids and constructs were maintained in Luria-Bertani broth supplemented with 380 
25% glycerol at -80o C in 1.5ml vials. E. coli strains were cultivated in an aerobic 381 
environment at 37o C for 16-24 hours. 382 
 383 
 384 
 385 
Bioinformatic tools and sequence analysis 386 
The nucleotide sequence and predicted protein sequence encoded by capC was 387 
downloaded in Fasta format from the CampyDB database resource at 388 
http://xbase.warwick.ac.uk/campydb/.  CapC is annotated as C8J_1278 in C. jejuni 389 
81116 and CJM1_1321 in C. jejuni M1. These sequences were used for all 390 
bioinformatics analyses. The NCBI Conserved Domain Database 391 
(http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi) is a publically available tool that 392 
can be used to annotate conserved domains in protein sequences. This tool was used 393 
to identify potential conserved domains in capC. The SignalP 4.1 server 394 
(http://www.cbs.dtu.dk/services/SignalP/) was used to predict putative signal peptides 395 
within CapC.  The subcellular localisation prediction tools Cello V2.5 396 
(http://cello.life.nctu.edu.tw/) and PSORTb (http://www.psort.org/psortb/index.html) 397 
were used to predict the localization site of CapC.  Phyre2 398 
(http://www.sbg.bio.ic.ac.uk/phyre2/html/page.cgi?id=index) was used to build a 399 
17 
 
partial 3D model of the CapC protein structure based on remote homology detection 400 
methods. 401 
 402 
Generation of capC-deficient mutants 403 
The capC gene in C. jejuni strains 81116 and M1 was inactivated using a 404 
chloramphenicol resistance cassette insert. The capC gene was amplified from C. 405 
jejuni strains 81116 and M1 using the CapCFW and CapCRV primers (Table 1) 406 
resulting in a 2893bp fragment. This fragment was cloned into pGEM T-easy and the 407 
resulting pJM005 was digested with BglII and XbaI cleaving the capC sequence after 408 
the 1501 and 2164 nucleotide positions respectively and thus excising a 647bp capC 409 
fragment from the plasmid. The chloramphenicol resistance (cat) cassette was 410 
amplified from pAV103 using the primers JMCAT5 and JMCAT6 [67], digested with 411 
BglII and XbaI and ligated into pJM005 thereby creating pJM007. A 1906bp fragment 412 
amplified from pJM007 using the Vac1 and Cap3 was used to transform C. jejuni 413 
81116 and M1 by electroporation according to the method of Holt et al. [68].  Table 1 414 
and Table S2 detail all oligonucleotide primers and plasmids used in this study 415 
respectively.  416 
 417 
Isolation of cellular fractions 418 
C. jejuni was harvested from agar plates and diluted in 10mM HEPES (Sigma, UK) to 419 
an OD600nm of 0.8 (approx. 5x107 cfu/ml). These bacterial suspensions were used to 420 
isolate supernatant, outer membrane, inner membrane and cytoplasmic fractions 421 
according to the method of Sommerlad and Hendrixson [69].  422 
 423 
Antiserum generation and Immunoblot analysis 424 
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Rabbit Polyclonal antibodies specific to CapC were generated using a synthetic 425 
peptide (EKLQQEAMQNGGKIDDEKY) designed with the Antigen Profiler software 426 
provided by Life Technologies (Thermo Fisher). New Zealand White rabbits were 427 
immunized over a period of 70 days and bled 3 times to obtain crude antibody sera. 428 
Immunoblotting was performed as described previously with minor modifications [69]. 429 
Membrane fractions were separated by sodium dodecyl sulphate polyacrylamide gel 430 
electrophoresis using 12.5% Novex Tris-Glycine pre-cast protein gels (Thermo 431 
Scientific, UK) and proteins were subsequently transferred to PVDF membranes 432 
(Fisher, UK) using a Pierce Power Blot cassette (Thermo Scientific, UK) using Pierce 433 
1-step Transfer Buffer (Thermo Scientific, UK). PVDF membranes were probed with 434 
with primary α-CapC antibody diluted 1:1000 in 10ml TBST with 3% milk powder for 1 435 
hour at room temperature. Membranes were washed and probed with Goat anti-rabbit 436 
secondary antibody conjugated to horse-radish peroxidase (Abcam #ab6721) diluted 437 
1:5000. Exposure and image capture was performed using a Licor Odyssey Fc imager. 438 
 439 
Galleria mellonella virulence model 440 
Galleria mellonella larvae were purchased from commercial suppliers Live Food or 441 
Live Foods Direct. Use of this model provides the basis for a rapid screening of 442 
virulence phenotypes within the context of a functional immune system comparable to 443 
that of mammals. Factors implicated as integral to Campylobacter infection of the 444 
human host have also been shown to contribute to insecticidal activity in this model 445 
[51, 66, 70]. Larvae were shipped at 5th or 6th instar stage (approximately 2-3 cm in 446 
length) and were suitable for use immediately. Larvae were maintained at 17oC on 447 
wood chips for up to two weeks. All larvae were handled using ethanol-sterilised blunt-448 
nosed forceps and examined prior to infection; any larvae showing discolouration or 449 
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signs of pupation were immediately discarded and euthanized. Healthy larvae were 450 
selected on the basis of their uniform creamy colour with no areas of dark discoloration 451 
and that were able to right themselves quickly if turned over.  C. jejuni strains were 452 
grown overnight and resuspended in PBS to an OD590 of 1 (1x108 cfu/ml).  This 453 
bacterial suspension was used to infect Galleria larvae.  Larvae were injected through 454 
the top right proleg with 10μl bacterial cell suspension.  Injection was performed using 455 
a Hamilton® 26S Micro-Syringe (Sigma).  Once infected, larvae were placed on a 456 
Whattman 90mm filter paper in an inverted Petri dish and incubated at 37oC for up to 457 
48 hours. A negative control in which larvae were injected with PBS only and a non-458 
infected control were also included.  Ten larvae were infected for each isolate in 459 
triplicate on four separate occasions. Mortality was confirmed by the inability of larvae 460 
to respond to physical stimuli [56]. 461 
 462 
Cell lines, media and culture conditions 463 
Caco-2 cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM, Gibco) 464 
supplemented with 10% Fetal Bovine Serum (FBS), 1% Non-essential amino acids 465 
and 1%(w/v) 100 U ml-1 penicillin/100μg ml-1 streptomycin. T84 cells were maintained 466 
in DMEM/F-12 Ham’s Nutrient Mix (Invitrogen) supplemented with 10% (v/v) Fetal Calf 467 
Serum (FCS), 1% (w/v) nonessential amino acids, and 100 U ml-1 penicillin/100μg ml-468 
1 streptomycin. For certain assays the media from Caco-2 or T84 cells was removed 469 
and the monolayers were washed twice with PBS and then maintained in antibiotic-470 
free and/or serum-free DMEM/F-12 medium. 471 
 472 
 473 
 474 
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Adhesion and Invasion assays 475 
CFU-based adherence assay and gentamicin protection assays were conducted as 476 
described previously with minor modifications [70, 71].  Caco-2 cells were seeded for 477 
1 week in 24-well plates at 1x106 cells ml-1 in 1ml of DMEM in 24-well plates and 478 
infected with 100 μl of C. jejuni suspensions prepared as described above at an MOI 479 
of 1:200.  Cells incubated at 37oC for 3.5 hours in a 5% CO2 humidified incubator. 480 
Monolayers were lysed with pre-warmed 1% (w/v) Triton-X 100 to release cell 481 
associated bacteria which were enumerated. A gentamicin protection assay was 482 
performed in conjunction with the adhesion assay.  After incubation for 3.5 hours, 483 
media was removed, monolayers were washed and complete DMEM supplemented 484 
with gentamicin to a final concentration of 150 μg ml-1 was added to each well. Plates 485 
were re-incubated for 2 hours at 37oC followed by bacterial enumeration.  486 
Adhesion and invasion efficiencies were calculated as described previously [71]. 487 
Additionally, the number of invaded bacteria as a proportion of associated bacteria 488 
(the number counted in adherence assays) was calculated. 489 
 490 
Cytotoxicity assay 491 
Cytotoxicity assays were performed using the Pierce LDH Cytotoxicity Assay Kit 492 
according to the manufacturers’ instructions (Thermofisher, UK).  Caco-2 cells were 493 
seeded at 1x105 per well of a 96-well plate in 100μl of complete DMEM for 48 hours. 494 
24 hour broth cultures of wildtype C. jejuni and capC mutants were resuspended in 495 
PBS to an OD590nm of 1.0, with 10μl of this suspension being used to inoculate the 496 
appropriate wells in triplicate. Serum-free DMEM and complete DMEM without cells 497 
were included to account for LDH activity in sera. Plates were incubated for 4 hours at 498 
37oC in a 5% CO2 humidified incubator. Absorbance was measure at 490nm and 499 
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680nm using a Wallac Plate Reader and the percentage cytotoxicity was calculated. 500 
These assays were performed in quintuplet on three different occasions. 501 
 502 
ELISA for IL-8 503 
The levels of IL-8 secretion from T84 cells were assessed using the eBioscience IL-8 504 
ELISA kit according to the manufacturer's instructions. T84 cells were infected with C. 505 
jejuni as described above. After 4 hours incubation the infected cell supernatant was 506 
removed and added to the wells of a 96-well Nunc Maxisorp® plate, in quadruplicate, 507 
which had been pre-blocked and exposed to a capture antibody specific for IL-8. 508 
Plates were incubated overnight and levels of IL-8 secretion were determined 509 
according to the manufacturer’s instructions. OD was measured on a Wallac Plate 510 
Reader at 450nm and the levels of IL-8 secretion determined. This assay was 511 
repeated three times. 512 
 513 
Statistical Analysis 514 
All statistical analyses were performed with Graphpad Prism (v 7.0; Graphpad 515 
Software). Data from wildtype and capC mutants was compared using a Mann-516 
Whitney test or an Unpaired t-test. Differences were considered significant at p<0.05. 517 
Virulence in the Galleria mellonella model was compared using multiple t-test function 518 
in Graphpad Prism v 7.0 (False-Discovery Rate=0.1) to obtain adjusted p-values (q-519 
values). 520 
 521 
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 815 
LEGENDS TO FIGURES 816 
 817 
Figure 1: Analysis of CapC domains the Conserved Domain Database query. The C-818 
terminal third of the CapC protein sequence is shown to possess an autotransporter 819 
domain confirming CapC as a member of the autotransporter family. 820 
Figure 2: Immunodetection of CapC using anti-CapC rabbit primary antibody and Goat 821 
anti-rabbit secondary antibody conjugated to HRP. A) Lane1: C. jejuni 81116 whole 822 
cell lysate, Lane 2: C. jejuni M1 whole cell lysate, Lane 3: C. jejuni 81116 capC mutant 823 
whole cell lysate, Lane 4: C. jejuni M1 capC mutant whole cell lysate. B) C. jejuni 824 
81116 wildtype cellular fractions.  Lane 1: concentrated supernatant fraction, Lane 2: 825 
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outer membrane fraction, Lane 3: inner membrane fraction, Lane 4: cytoplasmic 826 
fraction.  C) C. jejuni M1 wildtype cellular fractions.  Lane 1: concentrated supernatant 827 
fraction, Lane 2: outer membrane fraction, Lane 3: inner membrane fraction, Lane 4: 828 
cytoplasmic fraction.   829 
 830 
Figure 3: Graphical representation of the larval survival assay performed with C. jejuni 831 
81116, C. jejuni M1 and their respective capC mutants. PBS, mock infections controls 832 
were also used. Deletion of capC in both C. jejuni 81116 and C. jejuni M1 causes 833 
increased survival of Galleria larvae over 48 hours. This decrease in becomes 834 
apparent as early as 4 hours post infection with the onset of larval death which 835 
decreases further thereafter. Comparison of mean survival at 24 hours post infection 836 
shows deletion of capC causes significantly decreased survival (C. jejuni 81116: 837 
p<0.05; C. jejuni M1: p<0.05). These assays were performed in duplicate (10 larvae 838 
per replicate) on three different occasions; error bars show standard deviation. P-839 
values obtained using an unpaired t-test. 840 
 841 
Figure 4: Morbidity and mortality of Galleria mellonella infected with C. jejuni 81116 842 
(panel A), C. jejuni M1 (panel B) and their respective capC mutants.  At 24 hours p.i., 843 
larvae were assessed for mortality, discolouration and ability to move and assigned a 844 
score based on the scoring system in Table S4. Mean virulence scores of biological 845 
replicates for each criterion, were converted to percentages of the maximum possible 846 
score and compared.   There were significant differences in the morbidity and mortality 847 
elicited by C. jejuni 81116 and its capC mutant, and in the morbidity and mortality 848 
elicited by C. jejuni M1 and its capC mutant. Morbidity and mortality scores were 849 
compared using the multiple t-test function in Graphpad Prism v7.03). These assays 850 
were performed in triplicate (10 larvae per replicate) on four different occasions; error 851 
bars show standard error of the mean. 852 
 853 
 854 
Figure 5: Adhesion and invasion capability of C. jejuni wildtype and capC mutant with 855 
intestinal epithelial cells. (A) Adhesion and invasion efficiencies of C. jejuni 81116, C. 856 
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jejuni M1, and capC mutants in a Caco-2 cell culture model infected at an MOI of 857 
1:200.  C. jejuni 81116 exhibited an adhesion efficiency of 0.174% whereas the capC 858 
mutants exhibited an adhesion efficiency of 0.014% (p=0.0067). C. jejuni M1 wildtype 859 
demonstrated a mean adhesion efficiency of 0.173% whereas the C. jejuni M1 capC 860 
mutant exhibited an adhesion efficiency of 0.0188 (p=0.033). The wildtype C. jejuni 861 
81116 strain exhibited greater invasion efficiency (0.002%) compared to the mutant 862 
strain (0.00039%) (p=0.048). C. jejuni M1 capC mutant had a significant impairment 863 
in its ability to invade Caco-2 cells as compared to the wildtype strain (p=0.03). These 864 
assays were performed in triplicate on three different occasions; error bars show 865 
standard error of the mean. 866 
(B) Adhesion and invasion efficiencies of C. jejuni 81116, C. jejuni M1, and capC 867 
mutants in a non-polarised T84 cell culture model infected at an MOI of 200. C. jejuni 868 
81116 wildtype and C. jejuni M1 wildtype demonstrate adhesion efficiencies of 0.59% 869 
and 1.6% respectively, as compared to 0.078% and 0.24% for their respective capC 870 
mutants (p>0.05). C. jejuni 81116 invasion efficiency was reduced from 0.019% to 871 
0.002% as a result of capC inactivation and C. jejuni M1 invasion efficiency was 872 
reduced from 0.039% to 0.014% (p>0.05). Assays were performed in triplicate on three 873 
different occasions; error bars show standard error of the mean. 874 
(C): The proportion of associated C. jejuni that survive gentamicin treatment in a Caco-875 
2 cell model and a T84 cell culture model. The viable count in CFU/ml of C. jejuni 876 
surviving gentamicin treatment is used to calculate invasion efficiency. Values shown 877 
are calculated as the number of invaded bacteria, divided by the number of associated 878 
bacteria and converted to percentages. The capC mutant strains show a slight 879 
increase in the proportion of invaded bacteria as compared to their coupled wildtype 880 
strains indicating that CapC likely does not cause a proportional decrease in invasion 881 
capacity (Mann-Whitney Test: C. jejuni 81116, p>0.999; C. jejuni M1 p>0.999). Error 882 
bars show standard error of the mean. 883 
 884 
Figure 6: The decrease in IL-8 (pg ml-1) secretion from T84 cells in response to 885 
infection with C. jejuni wildtype and capC mutant strains (MOI=1:100). Infection of 886 
T84s with capC mutants caused a decrease in levels of IL-8 secretion from T84 cells. 887 
The greatest decrease was observed in C. jejuni M1 capC (p=0.0081). Error bars show 888 
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standard error of the mean. This assay was performed in quadruplicate on three 889 
occasions.  890 
 891 
Table 1: List of Oligonucleotide primers used in this study. 892 
        
Primer Name Primer Sequence (5'- 3') Restriction Site Source 
        
Cap1 CAATTAGGAAGTATAGGCGCA N/A This Study 
Cap2 AGCACCCACTTCAACACTTAC N/A This Study 
Vac1 GTGTAATCATCACCACTATTGATA N/A This Study 
JMCAT5 AAAAGATCTCTCGGCGGTGTTCCTTTCCAAG BglII This Study 
JMCAT6 GATTCTAGACGCCCTTTAGTTCCTAAAGGGT XbaI This Study 
CC069 ATATGTGCAGGGCGTATTGC N/A  [37] 
Cj0046F CACTACCCAATTGAAAATCTAAG N/A  [72] 
Cj0046R GTGAGTTAATGCCATCATAAC N/A  [72] 
Cap3 CCAAATGGATTATCAAGGC N/A This Study 
Cap4 GCTTGTTTATCTACTCCCACGG N/A This Study 
CapC-Fw ACTTGGCTTCGACAGGAGT N/A This Study 
CapC-Rv AAGATAAAGCCCTAGGAGATTTC N/A This Study 
BamCapC-FW GATGGATCCTGAAGGAGAAACTTATGAAG BamHI This Study 
BamCapC-RV GATGGATCCAAGATAAAGCCCTAGGAGATTTC BamHI This Study 
pSV009FW1 TAATAGAAATTTCCCCAAGTCCCA N/A  [37] 
pSV009RV1 CTATTGCCATAGTAGCTCTTAGTGG N/A  [37] 
CapCFBam GATGGATCCACTTGGCTTCGACAGGAGT BamHI This Study 
CapCRXho GATCTCGAGAAGATAAAGCCCTAGGAGATTTC XhoI This Study 
 893 
